US FTC Diagnoses Omicron Symptom: More Fraudulent COVID-19 Treatment Claims
Agency says emergence of Omicron variant spurred marketers of products and services from peptide therapy to herbal remedies, and from nasal irrigation to intravenous drips to make false COVID-19 claims.
You may also be interested in...
CofixRx and Sensory Cloud are latest OTC nasal spray marketers FDA warned about fraudulent COVID-19 claims. While the others’ violations were limited to violative claims, CofixRx also warned the active ingredient in its spray is limited to topical use.
Todos Medical, warned in 2021 about COVID-19 claims, could prompt a second warning about linking Tollovid to the coronavirus with recent announcement of test results. Firm also has appointed VPs of marketing and of government affairs since FTC in April 2021 warned about claims on its website, its social media pages and in a store.
FDA adds Soda Pharm of Ohio, Viraldine of New York and Bea Lydecker’s Naturals of Oregon to its list of businesses warned about sales of COVID-19- related products in violation of FDA regulations, which numbered 203 through 15 March.